NoduleRisk vs Radcalc Reference

NoduleRisk is a clinical decision support tool for physicians evaluating pulmonary nodule malignancy risk. It computes probability estimates and management guidance across five validated models simultaneously. MODELS INCLUDED • Mayo Clinic (ACCP) — logistic regression model for incidentally detected nodules • Brock (BTS/PanCan) — recommended for screening populations; validated in the Pan-Canadian Lung Cancer Screening Study • Herder (BTS) — incorporates FDG-PET/CT uptake when available • BIMC (Bayesian) — Bayesian likelihood ratio model with adjustable prior probability; displays individual likelihood ratio contributions • Fleischner 2017 — guideline-based follow-up recommendations with automatic risk stratification FEATURES • Multi-nodule evaluation (up to 6 nodules per patient) • Volume doubling time calculation from serial CT measurements • Risk-stratified management recommendations for each model • Applicability warnings when inputs are outside model validation ranges • Clinical context adjustments for screening and biopsy-referred populations • Fully offline — no data is transmitted or stored IMPORTANT NoduleRisk is intended for use by qualified clinicians as a decision support aid only. Results must be interpreted in the context of the full clinical picture and do not substitute for institutional guidelines, multidisciplinary team discussion, or clinical judgment.

Radcalc is an offline-first reference tool for radiologists and imaging professionals. It brings together radiology calculators, incidental findings pathways, and tumor response criteria in a focused native app. Use calculator tools for orientation, browse condensed incidental-finding pathways, and review tumor-response criteria with cited references. All core content is bundled for offline access. Results and references are intended to support professional review, not replace clinical judgment. For educational and professional reference only. Radcalc is not a medical device and does not provide diagnosis or treatment. Verify results against the cited source guideline, local policy, and professional clinical judgment. Do not use for emergencies.